Treatment recommendations in long‐chain fatty acid oxidation defects: consensus from a workshopUte Spiekerkoetter, U. Wendel, Matthias R. Baumgartner et al.|Journal of Inherited Metabolic Disease|2009Cited by 223
Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatasePaul Harmatz, Celeste Decker, Roberto Giugliani et al.|Molecular Genetics and Metabolism|2008Cited by 216